kongre.net
Welcome to kongre.net

Keynote speaker

Becca Senter

Chief Scientific Officer, Vertero Therapeutics

Becca Senter, Chief Scientific Officer at Vertero Therapeutics, gave a keynote at 10th MASH Drug Development Summit 2026 (Boston, United States of America, 15–17 Sept 2026) in the session “Targeting Bile Salt Hydrolase with the Oral Small Molecule VT-6382 as a Novel and Differentiated Approach to Treating MASH and Liver Fibrosis”.

Conferences
1
Keynotes
1
Upcoming
0

Past appearances

More speakers at 10th MASH Drug Development Summit 2026

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Becca Senter, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].